Aspire-Lakewood Holdings, Inc.

ASBPW ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item FY2025
Revenue $6.2K
Cost of Revenue $6.3K
Gross Profit $-116
Gross Margin -1.9%
Operating Expenses
Research & Development $923.9K
SG&A Expense $17.6M
Operating Income $-19.4M
Operating Margin -312,016.9%
Interest Expense —
Pretax Income $-24.5M
Income Tax Expense —
Net Income $-24.5M
Net Margin -394,725.1%
EPS (Basic) —
EPS (Diluted) $-16.38
Shares Outstanding (Basic) 1.5M
Shares Outstanding (Diluted) 1.5M
Dividends Per Share —